Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
NeoStem Inc. (NYSEMKT: NBS) shares spiked 4.13 percent to close at $0.53 a share Monday. The stock traded in between $0.51 and $0.55 on volume of 1.13 million shares traded. Analysts at Aegis Capital have recently initiated coverage on the company with a “buy” rating. Shares of NeoStem have fallen approximately 11.0 percent year-to-date.
Find out more about NeoStem including full access to the free equity report at:
Prologis Inc. (NYSE: PLD) shares declined 1.43 percent to close at $35.84 a share Monday. The stock traded in between $35.11 and $36.64 on volume of 4.93 million shares traded. Analysts at UBS have recently upgraded the company’s rating to “buy” from “neutral”. Shares of Prologis have fallen approximately 15.5 percent in the past month.
Find out more about Prologis including full access to the free equity report at:
Westlake Chemical Corporation (NYSE: WLK) shares increased 1.38 percent to close at $95.18 a share Monday. The stock traded between $91.02 and $95.98 on volume of 752,087 shares traded. Analysts at Cowen have recently upgraded the company’s rating to “outperform” from “neutral”. Shares of Westlake Chemical have gained approximately 20.0 percent year-to-date.
Find out more about Westlake Chemical including full access to the free equity report at:
YY Inc. (NASDAQ: YY) shares declined 13.02 percent to close at $23.99 a share Monday. The stock traded between $23.06 and $26.00 on volume of 1.69 million shares traded. Chinese Equities were dragged down by a 5.3 percent drop in the Shanghai Composite Index. Shares of YY have gained approximately 68.2 percent year-to-date.
Find out more about YY including full access to the free equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Research Driven Investing